Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer.
Laura EvangelistaGianluca CassarinoAlberto LauroAlessandro MorlaccoMatteo SepulcriAlex Ahn Li NguyenFrancesco IettoDiego CecchinCarmelo LacognataPietro ZucchettaPublished in: Abdominal radiology (New York) (2021)
FCH PET/MRI has a higher detection rate than MRI or PET alone for PCa patients with OMD and PSA levels > 0.5 ng/mL, prompting a better choice of treatment.